Credit Suisse’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-879
Closed -$29K 4190
2019
Q1
$29K Buy
+879
New +$45.1K ﹤0.01% 3925
2018
Q4
Sell
-1,659
Closed -$233K 3955
2018
Q3
$233K Sell
1,659
-934
-36% -$113K ﹤0.01% 3614
2018
Q2
$319K Buy
+2,593
New +$220K ﹤0.01% 3607
2017
Q3
Sell
-5,585
Closed -$235K 4230
2017
Q2
$235K Buy
+5,585
New +$286K ﹤0.01% 3572
2017
Q1
Sell
-3,205
Closed -$122K 3954
2016
Q4
$122K Buy
3,205
+2,130
+198% +$86.4K ﹤0.01% 3916
2016
Q3
$42K Sell
1,075
-2,195
-67% -$99.7K ﹤0.01% 4031
2016
Q2
$234K Buy
3,270
+1,043
+47% +$82.4K ﹤0.01% 3800
2016
Q1
$178K Sell
2,227
-2,365
-52% -$187K ﹤0.01% 3718
2015
Q4
$346K Buy
4,592
+3,853
+521% +$619K ﹤0.01% 3615
2015
Q3
$284K Sell
739
-3,366
-82% -$1.52M ﹤0.01% 3752
2015
Q2
$1.71M Buy
4,105
+1,993
+94% +$834K ﹤0.01% 2677
2015
Q1
$1M Buy
2,112
+1,368
+184% +$649K ﹤0.01% 2970
2014
Q4
$275K Buy
+744
New +$192K ﹤0.01% 4103

Other funds holding LRMR